GEn1E gets exclusive rights to UMB's p38a kinase inhibitor program

13 Feb 2020

·www.bioportfolio.com

GEn1E Lifesciences Inc. received exclusive global rights to the University of Maryland, Baltimore’s specific and function s...

Organizations

GEn1E Lifesciences, Inc.

University of Maryland

Indications

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.